Cormedix Inc (CRMD)
4.31
-0.02
(-0.46%)
USD |
NASDAQ |
Jun 28, 16:00
4.32
+0.01
(+0.23%)
After-Hours: 20:00
Cormedix SG&A Expense (TTM): 43.24M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 43.24M |
December 31, 2023 | 35.80M |
September 30, 2023 | 28.00M |
June 30, 2023 | 24.82M |
March 31, 2023 | 22.86M |
December 31, 2022 | 20.01M |
September 30, 2022 | 18.98M |
June 30, 2022 | 18.19M |
March 31, 2022 | 16.50M |
December 31, 2021 | 16.35M |
September 30, 2021 | 15.58M |
June 30, 2021 | 15.44M |
March 31, 2021 | 15.31M |
December 31, 2020 | 13.88M |
September 30, 2020 | 12.77M |
June 30, 2020 | 11.71M |
March 31, 2020 | 11.05M |
December 31, 2019 | 9.865M |
September 30, 2019 | 9.401M |
June 30, 2019 | 8.782M |
March 31, 2019 | 8.157M |
December 31, 2018 | 8.075M |
September 30, 2018 | 7.830M |
June 30, 2018 | 7.809M |
March 31, 2018 | 7.915M |
Date | Value |
---|---|
December 31, 2017 | 8.652M |
September 30, 2017 | 9.117M |
June 30, 2017 | 9.443M |
March 31, 2017 | 9.361M |
December 31, 2016 | 8.770M |
September 30, 2016 | 8.604M |
June 30, 2016 | 9.234M |
March 31, 2016 | 9.621M |
December 31, 2015 | 10.26M |
September 30, 2015 | 9.521M |
June 30, 2015 | 8.159M |
March 31, 2015 | 7.507M |
December 31, 2014 | 7.327M |
September 30, 2014 | 7.326M |
June 30, 2014 | 6.244M |
March 31, 2014 | 5.450M |
December 31, 2013 | 3.489M |
September 30, 2013 | 2.163M |
June 30, 2013 | 2.405M |
March 31, 2013 | 1.873M |
December 31, 2012 | 1.857M |
September 30, 2012 | 2.199M |
June 30, 2012 | 2.329M |
March 31, 2012 | 2.850M |
December 31, 2011 | 3.149M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
9.401M
Minimum
Sep 2019
43.24M
Maximum
Mar 2024
18.93M
Average
16.35M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
ACADIA Pharmaceuticals Inc | 413.31M |
Cassava Sciences Inc | 15.84M |
Vertex Pharmaceuticals Inc | 1.238B |
Regulus Therapeutics Inc | 10.30M |
Oragenics Inc | 5.999M |